Pharmacy Board Warns Against Falsified Lucentis Injection in Kenya
The Pharmacy and Poisons Board has warned the public and healthcare providers against a falsified Lucentis (Ranibizumab) 0.3mg injection that has been detected in circulation in the Kenyan market. The affected products bear batch numbers 18862110 and 18802112 and misleadingly claim to have been manufactured by Genentech. Pharmacy and Poisons Board Chief Executive Officer Dr [...] The post…
The Pharmacy and Poisons Board in Kenya has issued a warning to the public and healthcare providers about a falsified Lucentis (Ranibizumab) 0.3mg injection circulating in the market. The counterfeit product, which bears batch numbers 18862110 and 18802112 and falsely claims to be manufactured by Genentech, was identified following investigations.
The fake Lucentis is labeled with a different dosage (0.3mg) and packaging (dark amber vial) compared to the genuine product (10mg/mL, clear glass vial). The board has emphasized the potential risks associated with the falsified injection, including incorrect active ingredient amounts, contaminants, or undeclared substances, which could compromise patient safety.
Healthcare professionals are urged to verify the authenticity of medicines before dispensing and report any encounters with the suspected products.
Brief written by urgent.news from KahawaTungu's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
